Using a Liquid Biopsy to Monitor Metastatic Breast Cancer Treatment
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult women (≥ 18 years of age) with proven diagnosis of adenocarcinoma of the breast with evidence of recurrent or metastatic disease not amenable to resection or radiation therapy with curative intent \[to be herein described as 'metastatic'\]
Locations
Other Locations
Canada
Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario
RECRUITING
Kingston
Sunnybrook Health Sciences Centre
RECRUITING
Toronto
Contact Information
Primary
Christopher R Mueller, Ph.D.
muellerc@queensu.ca
613-533-6751
Backup
Keira Frosst
16kmf4@queensu.ca
613-533-6773
Time Frame
Start Date: 2023-10-19
Estimated Completion Date: 2026-04
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Collaborators: Canadian Institutes of Health Research (CIHR), Queen's University
Leads: Dr. Christopher Mueller